Picture of Sinopharm logo

1099 — Sinopharm News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedLarge CapContrarian

China's Sinopharm Group rises most in 5-1/2 months on solid H1 results

** Shares of China's pharmaceutical products distributor
Sinopharm Group Co Ltd  1099.HK  surge as much as 5.7% to
HK$23.10, their highest since Aug 7
    ** Stock marks biggest intraday pct gain since March 16
    ** The Shanghai-based co posts an 11.1% YoY growth in H1
profit to 4.10 bln yuan ($562.90 mln) with revenue up 15.1% YoY
to 300.95 bln yuan due to recovery of medical services demand
and deepening of medical reform amid relaxation of pandemic
control measures 
    ** The Hang Seng Commerce & Industry Index  .HSNC  rises
1.9%, healthcare index  .HSCIH  jumps 3.1% and the Hang Seng
Index  .HSI  climbs 1.7%
    ** As of last close, stock up 10.1% this year

    ($1 = 7.2837 Chinese yuan)

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))

Recent news on Sinopharm

See all news